Eric Zhang
Algemeen Directeur bij AKSO Biopharmaceutical, Inc.
Vermogen: 174 010 $ op 31-12-2023
Profiel
Eric Zhang is the founder of AKSO Biopharmaceutical, Inc. Prior to founding AKSO Biopharmaceutical, he worked as a Director at Versartis, Inc. He also worked as a Director at Aravive Biologics, Inc. from 2016 to 2018.
From 2018 to 2023, he served as an Independent Director at Aravive, Inc. Mr. Zhang received his undergraduate degree from Queen's University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARAVIVE, INC.
1.91% | 03-08-2023 | 1 403 303 ( 1.91% ) | 174 010 $ | 31-12-2023 |
Actieve functies van Eric Zhang
| Bedrijven | Functie | Begin |
|---|---|---|
| AKSO Biopharmaceutical, Inc. | Algemeen Directeur | - |
Eerdere bekende functies van Eric Zhang
| Bedrijven | Functie | Einde |
|---|---|---|
| ARAVIVE, INC. | Directeur/Bestuurslid | 02-10-2023 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Directeur/Bestuurslid | 01-10-2018 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | - |
Opleiding van Eric Zhang
| Queen's University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |